India: Treat For Tennis Fans – Sharapova Ban Reduced

Last Updated: 7 October 2016
Article by Alishan Naqvee and Dhruv Manchanda

The Court of Arbitration for Sports ("CAS") has finally given its arbitral award ("CAS Award") in the dispute between Ms. Maria Sharapova and the International Tennis Federation ("ITF") wherein Sharapova had challenged the 2 year ban imposed by the Independent Tribunal appointed by the ITF ("Tribunal") in its decision dated June 6, 2016 (Decision) (which has been analysed in detail in our earlier article circulated on July 4, 2016, also available at The ban was imposed on Sharapova for committing an anti-doping rule violation under article 2.1 of the Tennis Anti-Doping Programme 2016 ("TADP").

Brief Facts and Arguments Presented in front of CAS Panel:

During the proceedings before the CAS, Sharapova after summarizing her personal and sporting history, underlined that she has throughout her career, maintained an immaculate disciplinary record and would never deliberately use prohibited substances and be in violation of the anti-doping rules. During her submissions, Sharapova while referring to the provisions of TADP prescribing consequences for violation of anti-doping rules, primarily referred to Article 10.5 of TADP which allows for a reduction in the penalty on the basis of the principle "No Significance Fault or Negligence". As per the CAS Award, during the proceedings, Sharapova, inter alia:

  • accepted that she bears some degree of fault and therefore does not plead a defence of "No Fault or Negligence";
  • agreed to disqualification of her results at the 2016 Australian Open and did not challenge the Decision in this regard;
  • confirmed that the lack of intentionality (in committing the violation for purposes of article 10.2.2 of the TADP) was acknowledged by the Tribunal and therefore the sanction should be 2 years of ineligibility;
  • emphasized that CAS has discretion to reduce the period of ineligibility to 1 year upon establishment of the principle "No Significant Fault or Negligence"; and
  • requested the CAS panel to exercise its discretion to reduce the ineligibility to a shorter period, consistent with the principle of proportionality.

Sharapova further described the extent and effectiveness of the system she had in place to ensure anti-doping compliance and underlined that "athletes are permitted to delegate elements of their anti-doping obligations. If a mistake later arises, the fault to be assessed is not that made by the delegate but the fault made by the athlete in his/her choice".

In light of the above statement, it was deliberated that "Sharapova cannot be faulted for relying on the services of one of the largest best resourced sports managements firms and of Mr Eisenbud, who had advised her since she was 11 years old, had performed thorough anti-doping checks and assistance for her over several years with diligence and urgency, and understood better than anybody the catastrophic consequences of a positive test."

Sharapova argued that the World Anti-Doping Agency ("WADA") was aware that Meldonium was widely known under the name of 'Mildronate' and a large number of athletes use 'Mildronate' but still failed to mention the name 'Mildronate' on the 2016 Prohibited List and to issue specific warnings in this regard. Sharapova, thus, contended that her error, to an extent, is also attributable to WADA's failure and therefore, under the circumstances, she met the the criteria of "No Significant Fault or Negligence".

The ITF had submitted that "this case has exposed the failure of the Appellant to take responsibility for discharging her anti-doping responsibilities herself (in particular, checking whether her medication contained any prohibited substances). Instead [she] delegated the job to her (hopelessly unqualified) manager, without giving him any proper instructions or procedures, or doing anything to supervise or control his work or to check that what he had done was sufficient to ensure she would not fall foul of the anti-doping rules. In such circumstances, it was hardly surprising that this arrangement failed completely, causing her to test positive in January 2016 for a drug, meldonium, that she had been taking for a long time but that had just been put onto the Prohibited List. In such circumstances, the rules and the constant CAS jurisprudence are clear: against the starting-point that she must use 'utmost caution' to ensure that no prohibited substance enters her system, the Appellant's failure to delegate her responsibilities to a properly qualified person, to provide proper instructions, to lay down proper procedures, and to supervise that person's compliance with those procedures, make her significantly negligent, and therefore the Independent Tribunal "was right not to give her any reduction from the two-year ban proscribed in the Code and the TADP".

After hearing both the parties, following issues were to be examined and decided upon by the CAS panel:

  1. What is the player's level of fault and more specifically, did the player commit the anti-doping rule violation with "No Significance Fault or Negligence"?
  2. If so, what is the proper sanction for period of ineligibility for the player?

Looking into the facts of the case and hearing both the parties, the CAS panel opined that:

  • Sharapova chose to rely on Mr. Eisenbud and his organization for performance of all anti-doping related matters, which choice was found to be reasonable by CAS panel. However, Sharapova did not establish any procedure to supervise and control the actions performed by Mr. Eisenbud while discharging the task he was entrusted to perform nor was there any procedure for reporting or verification to ensure actual discharge of duties by Mr. Eisenbud; and
  • Sharapova had reduced perception of the risk being incurred while using 'Mildronate' due to number of reasons which, inter alia, included that 'Mildronate' was initially consumed by Sharapova under the supervision and prescription of Dr. Skalny (post verification of the substance from ITF) and the same was consumed for medical reasons and not as a performance enhancing drug.

Final Award:

Sharapova's claim to the principle of "No Significant Fault or Negligence" was accepted by CAS panel. For the purposes of period of ineligibility, the CAS panel noted that Sharapova does bear some degree of fault which prevents reduction of the period of ineligibility to the minimum prescribed period under the TADP. CAS panel thus decided that an ineligibility period of 15 months is appropriate to the degree of fault attributable to Sharapova.

Effects of the Award:

Post the CAS Award, Sharapova has made a public statement claiming that October 4, 2016 has been one of her happiest days and is planning a strong return to the tennis circuit in 2017.

2016 has arguably been one of the historic years in women tennis, during which the game saw two new first time grand slam champions [Angelique Kerber winning the Australian Open and US Open (eventually gaining number 1 rank) and Garbine Muguruza winning the French Open] and Monica Puig winning the Olympic gold medal.

Sharapova, having won all 4 grand slams at least once, and settling for silver at the London Olympics in 2012, would have been eagerly looking forward to lay her hands on gold in Rio Olympics in 2016. Thus, the ban imposed on Sharapova definitely was a great setback for Sharapova in her tennis career and came possibly at the most dreaded time, as it took away the opportunity of participating in Rio Olympics.

However, the CAS Award has come as a big relief and the reduced period of ineligibility 15 months is deemed to be commencing from January 26, 2016 till midnight of April 25, 2017. This effectively means that Sharapova will be missing out on the hard court season of tennis tournaments in beginning of 2017 and her first tennis tournament will be the clay court tournament beginning the week of May 1, 2017 in Prague, Czech Republic or in Rabat, Morocco.

This also means that for second consecutive year Sharapova will be missing out on the opportunity of participating in the Stuttgart Open by 2 days as the tournament is scheduled for the week of April 24, 2017. Stuttgart Open and has arguably been one of Sharapova's most preferred clay court tournaments where she won for 3 (three) consecutive years from 2012 to 2014.

At the time of her return, Sharapova will have no ranking points and will be dependent on wild cards for her comeback tournaments as she has not had a chance of defending her ranking points for any of the tournaments in 2016. Sharapova will have a chance of participating in maximum 4 tournaments to play some competitive tennis, gain her form back and also gain some ranking points before the French Open, 2017 (scheduled to commence on May 29, 2017). The women singles draw of the French Open, 2017 will be an interesting proposition as Sharapova will most likely be going into the draw as an unseeded player. Sharapova, in all probabilities, would be looking to climb the rankings as early as possible and go into Wimbledon (being one of her favourite tournaments) as a seeded player. Sharapova on the centre court would be a sight for sore eyes, for she was missing in action at the 2016 Wimbledon Championships.

Another noteworthy proposition is that the timing of Sharapova's return to professional tennis is the beginning of the clay court season which is not the most preferred surface for Sharapova, even though during her career she has won 12 clay court tournaments which includes French Open in 2012 and 2014.

Sharapova's return in May, 2017 will be eagerly awaited by the tennis fraternity and fans across the globe. The 15-month break from tennis although quite stressful from the player's perspective, may prove to be a blessing in disguise for Sharapova, as the rest for her muscles and body during this period may eventually help her prolong her tennis career. Sharapova will definitely be looking for a strong comeback and go on to add some more trophies to her cabinet and will also be looking at strengthening her chances of participating in the 2020 Tokyo Olympics and claiming an Olympic gold medal to add to her already accomplished tennis achievements.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Alishan Naqvee
Dhruv Manchanda
In association with
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions